Correlation Between FormPipe Software and Scandinavian ChemoTech

Can any of the company-specific risk be diversified away by investing in both FormPipe Software and Scandinavian ChemoTech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining FormPipe Software and Scandinavian ChemoTech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between FormPipe Software AB and Scandinavian ChemoTech AB, you can compare the effects of market volatilities on FormPipe Software and Scandinavian ChemoTech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in FormPipe Software with a short position of Scandinavian ChemoTech. Check out your portfolio center. Please also check ongoing floating volatility patterns of FormPipe Software and Scandinavian ChemoTech.

Diversification Opportunities for FormPipe Software and Scandinavian ChemoTech

0.62

Correlation Coefficient

FormPipe Software  Scandinavian ChemoTech

Poor diversification

The 3 months correlation between FormPipe and Scandinavian is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding FormPipe Software AB and Scandinavian ChemoTech AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Scandinavian ChemoTech and FormPipe Software is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on FormPipe Software AB are associated (or correlated) with Scandinavian ChemoTech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Scandinavian ChemoTech has no effect on the direction of FormPipe Software i.e., FormPipe Software and Scandinavian ChemoTech go up and down completely randomly.

Pair Corralation between FormPipe Software and Scandinavian ChemoTech

Assuming the 90 days trading horizon FormPipe Software AB is expected to generate 0.57 times more return on investment than Scandinavian ChemoTech. However, FormPipe Software AB is 1.76 times less risky than Scandinavian ChemoTech. It trades about 0.02 of its potential returns per unit of risk. Scandinavian ChemoTech AB is currently generating about -0.03 per unit of risk. If you would invest  2,614  in FormPipe Software AB on September 3, 2024 and sell it today you would earn a total of  36.00  from holding FormPipe Software AB or generate 1.38% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

FormPipe Software AB  vs.  Scandinavian ChemoTech AB

FormPipe Software

Risk-Adjusted Performance

1 of 100

Very Weak

Compared to the overall equity markets, risk-adjusted returns on investments in FormPipe Software AB are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, FormPipe Software is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Scandinavian ChemoTech

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Scandinavian ChemoTech AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong technical and fundamental indicators, Scandinavian ChemoTech is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with FormPipe Software and Scandinavian ChemoTech

The main advantage of trading using opposite FormPipe Software and Scandinavian ChemoTech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if FormPipe Software position performs unexpectedly, Scandinavian ChemoTech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Scandinavian ChemoTech will offset losses from the drop in Scandinavian ChemoTech's long position.

The idea behind FormPipe Software AB and Scandinavian ChemoTech AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.